|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 14031 |
FusionGeneSummary for FTH1_FAM162A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FTH1_FAM162A | Fusion gene ID: 14031 | Hgene | Tgene | Gene symbol | FTH1 | FAM162A | Gene ID | 2495 | 26355 |
| Gene name | ferritin heavy chain 1 | family with sequence similarity 162 member A | |
| Synonyms | FHC|FTH|FTHL6|HFE5|PIG15|PLIF | C3orf28|E2IG5|HGTD-P | |
| Cytomap | 11q12.3 | 3q21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ferritin heavy chainapoferritincell proliferation-inducing gene 15 proteinferritin H subunitferritin, heavy polypeptide 1placenta immunoregulatory factorproliferation-inducing protein 15 | protein FAM162AE2-induced gene 5 proteinHIF-1 alpha-responsive proapoptotic moleculegrowth and transformation-dependent protein | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | P02794 | Q96A26 | |
| Ensembl transtripts involved in fusion gene | ENST00000529631, ENST00000529191, ENST00000273550, ENST00000526640, ENST00000532601, | ENST00000232125, ENST00000477892, ENST00000469967, | |
| Fusion gene scores | * DoF score | 6 X 6 X 1=36 | 3 X 3 X 2=18 |
| # samples | 6 | 3 | |
| ** MAII score | log2(6/36*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: FTH1 [Title/Abstract] AND FAM162A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FTH1 | GO:0006880 | intracellular sequestering of iron ion | 9924025 |
| Hgene | FTH1 | GO:0048147 | negative regulation of fibroblast proliferation | 9924025 |
| Tgene | FAM162A | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 15082785 |
| Tgene | FAM162A | GO:0043065 | positive regulation of apoptotic process | 15082785 |
| Tgene | FAM162A | GO:0071456 | cellular response to hypoxia | 15082785 |
| Tgene | FAM162A | GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 15082785 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW020886 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000529631 | ENST00000232125 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000529631 | ENST00000477892 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000529631 | ENST00000469967 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000529191 | ENST00000232125 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000529191 | ENST00000477892 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000529191 | ENST00000469967 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000273550 | ENST00000232125 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000273550 | ENST00000477892 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000273550 | ENST00000469967 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000526640 | ENST00000232125 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000526640 | ENST00000477892 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000526640 | ENST00000469967 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000532601 | ENST00000232125 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000532601 | ENST00000477892 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
| intron-3CDS | ENST00000532601 | ENST00000469967 | FTH1 | chr11 | 61732036 | - | FAM162A | chr3 | 122126184 | + |
Top |
FusionProtFeatures for FTH1_FAM162A |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FTH1 | FAM162A |
| Stores iron in a soluble, non-toxic, readily availableform. Important for iron homeostasis. Has ferroxidase activity.Iron is taken up in the ferrous form and deposited as ferrichydroxides after oxidation. Also plays a role in delivery of ironto cells. Mediates iron uptake in capsule cells of the developingkidney (By similarity). {ECO:0000250}. | Proposed to be involved in regulation of apoptosis; theexact mechanism may differ between cell types/tissues. May beinvolved in hypoxia-induced cell death of transformed cellsimplicating cytochrome C release and caspase activation (such asCASP9) and inducing mitochondrial permeability transition. May beinvolved in hypoxia-induced cell death of neuronal cells probablyby promoting release of AIFM1 from mitochondria to cytoplasm andits translocation to the nucleus; however, the involvement ofcaspases has been reported conflictingly.{ECO:0000269|PubMed:15082785}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FTH1_FAM162A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FTH1_FAM162A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FTH1_FAM162A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | FTH1 | P02794 | DB01592 | Iron | Ferritin heavy chain | small molecule | approved |
Top |
RelatedDiseases for FTH1_FAM162A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | FTH1 | C0011581 | Depressive disorder | 1 | CTD_human |
| Hgene | FTH1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
| Hgene | FTH1 | C0017638 | Glioma | 1 | CTD_human |
| Hgene | FTH1 | C0022548 | Keloid | 1 | CTD_human |
| Hgene | FTH1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Hgene | FTH1 | C0032927 | Precancerous Conditions | 1 | CTD_human |
| Hgene | FTH1 | C0282193 | Iron Overload | 1 | CTD_human |
| Hgene | FTH1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
| Hgene | FTH1 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|